27 Percent Quarterly Profit Growth Stocks to Buy in November 2026: 5 Names on the Watchlist

The 27 percent quarterly profit growth stocks to buy in November 2026 start with five listed names: Bajaj Finance, KEI Industries, Metropolis Healthcare, Oracle Financial Services Software and Sun Pharmaceutical Industries. These five companies each grew net profit by about 26% to 29% in the latest reported quarter compared with a year earlier. Bajaj Finance and Sun Pharmaceutical Industries are part of the Nifty 50 index, Bajaj Finance is part of the Nifty Fin Service index and Sun Pharmaceutical Industries is part of the Nifty Pharma index.

This article ranks none of them as a sure thing. It lays out the numbers each company has reported, how the shares are priced today and what an investor should check before adding any of these 27 percent quarterly profit growth stocks to buy to a portfolio. All prices are NSE closing prices of 12 November 2026, and financials come from company filings.

Click Here – Get Free Investment Predictions

Which Are the Best 27 Percent Quarterly Profit Growth Stocks to Buy in November 2026?

The best 27 percent quarterly profit growth stocks to buy in November 2026 for a watchlist are Bajaj Finance, KEI Industries, Metropolis Healthcare, Oracle Financial Services Software and Sun Pharmaceutical Industries. They were picked because each has complete reported financials, profit in the latest quarter and an NSE listing. The table puts their market data side by side.

Company	CMP (Rs)	Market Cap	P/E	ROE	Dividend Yield
Bajaj Finance	1,115	Rs 5,71,076 crore	25.88	17.61%	0.65%
KEI Industries	4,136	Rs 36,843 crore	34.90	14.66%	0.12%
Metropolis Healthcare	565.20	Rs 11,493 crore	56.65	12.56%	0.90%
Oracle Financial Services Software	10,000	Rs 86,964 crore	24.37	46.42%	4.00%
Sun Pharmaceutical Industries	1,885	Rs 4,22,991 crore	34.91	13.74%	0.91%

On valuation, KEI Industries trades below the industry P/E; Metropolis Healthcare and Sun Pharmaceutical Industries sit close to it; Bajaj Finance and Oracle Financial Services Software carry a premium. Valuation is the first filter for any 27 percent quarterly profit growth stocks to buy list, and it is covered again in the risk section.

Why These 27 Percent Quarterly Profit Growth Stocks to Buy Are in Focus

In this list, FY26 net profit and revenue both grew for every company, and quarterly profit in the latest reported quarter was higher than a year earlier for all five. The list covers the country's largest non-bank lender, a cables and wires maker, a diagnostics chain, a banking software company and the largest pharma company by sales. Investors comparing the best stocks with 27 percent quarterly profit growth in India usually check whether growth is steady, how the shares are valued and how much debt the company carries.

Bajaj Finance: The NBFC Leader Among 27 Percent Quarterly Profit Growth Stocks to Buy

Bajaj Finance is India's largest non-banking finance company by market value, lending across consumer, SME and mortgage segments. Its market capitalisation is Rs 5,71,076 crore, the share price is Rs 1,115 and the P/E of 25.88 compares with an industry P/E of 16.13.

Over FY26, net profit rose 15.2% to Rs 19,332 crore on revenue of Rs 81,990 crore, which was up 19.1%. The latest quarter, the September 2026 quarter, brought revenue of Rs 24,576 crore, up 22.9% year on year, and net profit of Rs 6,367 crore, up 28.7%.

Return on equity is 17.61%, and the dividend yield is 0.65%. Promoters hold 54.67%, foreign institutions 19.79% and domestic institutions 17.05% as of September 2026. Domestic institutional holding has risen from 14.47% to 17.05% over the last year.

KEI Industries: The Power Cable Specialist Among 27 Percent Quarterly Profit Growth Stocks to Buy

KEI Industries is a maker of power cables, including extra-high-voltage cables, along with stainless steel wire. The stock trades at Rs 4,136 with a market capitalisation of Rs 36,843 crore and a P/E of 34.90, against an industry P/E of 39.42.

FY26 revenue rose 21.4% to Rs 11,906 crore and net profit rose 31.9% to Rs 918 crore. In the September 2026 quarter, revenue grew 37.3% year on year to Rs 3,801 crore, while net profit grew 29.0% to Rs 262 crore.

Return on equity is 14.66%, debt-to-equity is 0.05, and the dividend yield is 0.12%. Promoters hold 35.00%, foreign institutions 26.14% and domestic institutions 26.26% as of September 2026.

Check 27 Percent Quarterly Profit Growth Stocks Live on the Univest Screener

Metropolis Healthcare: The Diagnostics Network Among 27 Percent Quarterly Profit Growth Stocks to Buy

Metropolis Healthcare is a diagnostics company with labs and collection centres across India and overseas. At Rs 565.20, the stock has a market capitalisation of Rs 11,493 crore and trades at 56.65 times earnings, while the industry P/E is 61.50.

Reported numbers show FY26 revenue of Rs 1,671 crore, up 24.1% year on year, with net profit at Rs 191 crore, up 31.4%. The June 2026 quarter added revenue of Rs 455 crore (up 15.7%) and net profit of Rs 56.9 crore (up 25.7%).

Return on equity is 12.56%, debt-to-equity is 0.15, and the dividend yield is 0.90%. Promoters hold 47.82%, foreign institutions 11.67% and domestic institutions 35.49% as of September 2026. Domestic institutional holding has risen from 33.10% to 35.49% over the last year.

Oracle Financial Services Software: The Banking Software Specialist Among 27 Percent Quarterly Profit Growth Stocks to Buy

Oracle Financial Services Software is a banking and financial software products company that is majority-owned by Oracle. Its market capitalisation is Rs 86,964 crore, the share price is Rs 10,000 and the P/E of 24.37 compares with an industry P/E of 18.92.

Over FY26, net profit rose 10.9% to Rs 2,639 crore on revenue of Rs 7,943 crore, which was up 11.1%. The latest quarter, the September 2026 quarter, brought revenue of Rs 1,972 crore, up 6.3% year on year, and net profit of Rs 702 crore, up 28.6%.

Return on equity is 46.42%, debt-to-equity is 0.00, and the dividend yield is 4.00%. Promoters hold 72.39%, foreign institutions 11.43% and domestic institutions 7.77% as of September 2026. Foreign institutional holding has risen from 8.65% to 11.43% over the last year.

Sun Pharmaceutical Industries: The Pharma Heavyweight Among 27 Percent Quarterly Profit Growth Stocks to Buy

Sun Pharmaceutical Industries is India's largest pharmaceutical company by market value, with a strong domestic franchise and a growing specialty portfolio in the US. The stock trades at Rs 1,885 with a market capitalisation of Rs 4,22,991 crore and a P/E of 34.91, against an industry P/E of 37.65.

FY26 revenue rose 12.7% to Rs 61,674 crore and net profit rose 5.3% to Rs 11,565 crore. In the June 2026 quarter, revenue grew 11.9% year on year to Rs 16,024 crore, while net profit grew 26.4% to Rs 2,911 crore.

Return on equity is 13.74%, debt-to-equity is 0.06, and the dividend yield is 0.91%. Promoters hold 52.68%, foreign institutions 14.36% and domestic institutions 22.27% as of September 2026. Domestic institutional holding has risen from 20.23% to 22.27% over the last year.

Download the Univest iOS App or Univest Android App to track these 27 percent quarterly profit growth stocks live and get daily stock recommendations.

Growth Snapshot: Latest Full Year and Latest Quarter

The table compares year-on-year growth in revenue and net profit for all five 27 percent quarterly profit growth stocks, using filed results.

Company	Full-Year Revenue Growth	Full-Year Profit Growth	Latest Quarter	Quarter Revenue Growth	Quarter Profit Growth
Bajaj Finance	19.1%	15.2%	Sep 2026	22.9%	28.7%
KEI Industries	21.4%	31.9%	Sep 2026	37.3%	29.0%
Metropolis Healthcare	24.1%	31.4%	Jun 2026	15.7%	25.7%
Oracle Financial Services Software	11.1%	10.9%	Sep 2026	6.3%	28.6%
Sun Pharmaceutical Industries	12.7%	5.3%	Jun 2026	11.9%	26.4%

Factors That Move 27 Percent Quarterly Profit Growth Stocks to Buy

Four factors tend to drive 27 percent quarterly profit growth stocks, and each one is worth checking before a purchase.

• Quarterly growth: Profit rose about 26% to 29% year on year.
• Dividends: Oracle Financial Services Software yields about 4.0%.
• Return on equity: Oracle Financial Services Software leads at about 46%.
• Valuation: P/E runs from about 24 to 57.

Risks to Keep in Mind Before Buying 27 Percent Quarterly Profit Growth Stocks

The first risk is that Metropolis Healthcare trades at a P/E near 57, while KEI Industries and Sun Pharmaceutical Industries trade near 35 and Oracle Financial Services Software trades near 24, so expectations differ. The second is that Bajaj Finance carries the highest borrowings of the five as a lender and Metropolis Healthcare is valued at only about Rs 11,500 crore. Check results every quarter.

On the numbers, Metropolis Healthcare trades at the highest P/E on this list at 56.65, so its earnings need to keep growing to support the price. 27 Percent Quarterly Profit Growth stocks to buy can still fall when markets turn weak, and a staggered entry has historically suited investors better than a lump-sum purchase.

How to Choose 27 Percent Quarterly Profit Growth Stocks to Buy

• Compare growth: KEI Industries grew FY26 profit most, by about 32%.
• Check P/E: Oracle Financial Services Software trades lowest.
• Read the yield: Oracle Financial Services Software pays the most.
• Spread sectors: Mix lending, cables, diagnostics, software and pharma.

How to Invest in 27 Percent Quarterly Profit Growth Stocks

1. Shortlist two or three companies from this list that match your risk appetite.
2. Open the Univest Screener and compare P/E, ROE and debt for each stock.
3. Check the latest quarterly results and shareholding pattern on NSE or BSE.
4. Decide an amount you can hold for three to five years and split it into two or three purchases.
5. Review the holding after every quarterly result instead of reacting to daily price moves.

Conclusion

Oracle Financial Services Software offers both the lowest P/E on this list at 24.37 and the highest return on equity at 46.42%, and KEI Industries posted the fastest net profit growth in its latest full year at 31.9%. Among the best 27 percent quarterly profit growth stocks in India, these five give investors a spread of size, valuation and growth, so the right pick depends on risk appetite and holding period. Spread the entry, keep position sizes sensible and consult a SEBI-registered advisor before investing in any of these 27 percent quarterly profit growth stocks to buy.

Frequently Asked Questions on 27 Percent Quarterly Profit Growth Stocks to Buy

Which are the best 27 percent quarterly profit growth stocks to buy in November 2026?

Ans. The five 27 percent quarterly profit growth stocks on the November 2026 watchlist are Bajaj Finance, KEI Industries, Metropolis Healthcare, Oracle Financial Services Software and Sun Pharmaceutical Industries. Oracle Financial Services Software has both the lowest P/E at 24.37 and the highest ROE at 46.42%, and KEI Industries grew net profit 31.9% in its latest full year. This is educational content, not investment advice, so please consult a SEBI-registered advisor.

Is Bajaj Finance a good stock to buy from this 27 Percent Quarterly Profit Growth list?

Ans. Bajaj Finance is the largest company on this list with a market capitalisation of Rs 5,71,076 crore and a P/E of 25.88 against an industry P/E of 16.13. Its FY26 revenue rose 19.1% and net profit rose 15.2%, with return on equity at 17.61%. Whether it suits you depends on your risk appetite and holding period, so please consult a SEBI-registered advisor before investing.

Are these 27 percent quarterly profit growth stocks expensive right now?

Ans. Valuations vary across the group. Bajaj Finance trades at a P/E of 25.88, KEI Industries trades at a P/E of 34.90, Metropolis Healthcare trades at a P/E of 56.65, Oracle Financial Services Software trades at a P/E of 24.37, Sun Pharmaceutical Industries trades at a P/E of 34.91, against industry multiples ranging from 16.13 to 61.50. Higher multiples reflect faster growth but also leave less room for earnings misses, so entry price deserves attention.

Which of these 27 percent quarterly profit growth stocks pay a dividend?

Ans. Dividend yields on this list are Bajaj Finance 0.65%, KEI Industries 0.12%, Metropolis Healthcare 0.90%, Oracle Financial Services Software 4.00%, Sun Pharmaceutical Industries 0.91%. Yields differ widely across the group, so check payout history and earnings cover before relying on any of them for income, since payouts can change with company profits.

Which stock on this list has the highest return on equity?

Ans. Oracle Financial Services Software has the highest ROE on this list at 46.42%, followed by Bajaj Finance at 17.61% and KEI Industries at 14.66%. A higher ROE shows a company earns more profit on shareholder capital, but it should be read alongside valuation and debt.

What are the risks of investing in 27 percent quarterly profit growth stocks?

Ans. The main risks are high valuations at three names, borrowings at the lender and a wide spread in sectors. On this list, Metropolis Healthcare trades at the highest P/E of 56.65, which leaves less room for earnings disappointments. Staggered buying and a long holding period can help manage these risks.

How can I invest in 27 percent quarterly profit growth stocks in India?

Ans. You can buy these stocks directly on NSE or BSE through a demat account, and compare them first on the Univest Screener using P/E, ROE and debt. Many investors split the amount across two or three purchases and review the holding after each quarterly result. Sector-themed mutual funds and ETFs are another route for investors who prefer diversification.